ZA201104679B - Suppression of cancers - Google Patents

Suppression of cancers

Info

Publication number
ZA201104679B
ZA201104679B ZA2011/04679A ZA201104679A ZA201104679B ZA 201104679 B ZA201104679 B ZA 201104679B ZA 2011/04679 A ZA2011/04679 A ZA 2011/04679A ZA 201104679 A ZA201104679 A ZA 201104679A ZA 201104679 B ZA201104679 B ZA 201104679B
Authority
ZA
South Africa
Prior art keywords
cancers
suppression
Prior art date
Application number
ZA2011/04679A
Inventor
Frederic Madec
Phil Lecane
Phillip Marks
Keith Foster
Original Assignee
Syntaxin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntaxin Ltd filed Critical Syntaxin Ltd
Priority to ZA2011/04679A priority Critical patent/ZA201104679B/en
Publication of ZA201104679B publication Critical patent/ZA201104679B/en

Links

ZA2011/04679A 2011-06-23 2011-06-23 Suppression of cancers ZA201104679B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA2011/04679A ZA201104679B (en) 2011-06-23 2011-06-23 Suppression of cancers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA2011/04679A ZA201104679B (en) 2011-06-23 2011-06-23 Suppression of cancers

Publications (1)

Publication Number Publication Date
ZA201104679B true ZA201104679B (en) 2012-03-28

Family

ID=56363262

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2011/04679A ZA201104679B (en) 2011-06-23 2011-06-23 Suppression of cancers

Country Status (1)

Country Link
ZA (1) ZA201104679B (en)

Similar Documents

Publication Publication Date Title
HK1245110B (en) Solid forms of isoquinolinones
HK1210180A1 (en) Derivatives of betulin
EP2813073A4 (en) Adaptive region of interest
IL228604A0 (en) Synthesis of 5 - azacytidine
EP2707710A4 (en) Diagnosis of cancer
PL2690985T3 (en) Piece of furniture
EP2868660A4 (en) Antitumor effect potentiator composed of imidazooxazine compound
IL236312A0 (en) Preparation of 18f-fluciclovine
EP2694705A4 (en) Microfrabication of tunnels
IL237862A0 (en) Methods of reducing scalant formation
HK1199737A1 (en) Treatment of coal
GB2510539B (en) Biomarkers of cancer
EP2892529A4 (en) Uses of (-)-perhexiline
EP2684869A4 (en) Preparation of 3-mercaptopropionates
EP2680843A4 (en) Derivatives of pyrazole-substituted amino-heteroaryl compounds
GB201104469D0 (en) Control of phagocytosis
ZA201502350B (en) Solid form of hihydro-pyrido-oxazine derivative
EP2732287A4 (en) Methods of diagnosing cancer
ZA201104679B (en) Suppression of cancers
IL229109A0 (en) Diognosis of cancer
GB201108347D0 (en) Polymprphic form of compound
SI2928896T1 (en) Solid form of dihydro-pyrido-oxazine derivative
GB201222952D0 (en) Treatent of cancer
ZA201104656B (en) Suppression of neuroendocrine diseases
TWM433525U (en) Structure of calorifier